The Gross Margin of Hansa Biopharma AB (HNSA.ST) is 51.23%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 51.23% |
2023-12-31 | 52.91% |
2022-12-31 | 75.10% |
2021-12-31 | 54.47% |
2020-12-31 | 83.65% |
2019-12-31 | 74.26% |
2018-12-31 | 72.72% |
2017-12-31 | 93.58% |
2016-12-31 | 91.59% |
2015-12-31 | 90.14% |